• Pitavastatin (NK-104): In Vitro Workflow Guide

  2026-08-19

  Pitavastatin (NK-104, SKU B1124) provides a defined HMG-CoA reductase inhibitor for controlled studies of cholesterol biosynthesis, with a dossier-reported HepG2 reference IC50 of 5.8 nM. This guide covers preparation, assay controls, and QC for in vitro work; it does not establish clinical, animal, or directly paper-matched applications.

• APEX2 Promotes TERT Expression in Human Stem Cells

  2026-08-18

  This study identifies APEX2 as a DNA repair factor required for efficient TERT expression in human embryonic stem cells and melanoma cells, distinguishing its function from the related enzyme APEX1. RNA-seq and chromatin immunoprecipitation connect APEX2-dependent transcription to repetitive DNA, especially MIR elements within TERT intron 2, suggesting that repair of damage-prone sequences can influence telomerase regulation.

• WM-8014: KAT6A Inhibitor Guide

  2026-08-18

  WM-8014 is a reversible, competitive KAT6A inhibitor with activity against KAT6B, KAT5, and KAT7. It supports mechanistic studies of histone acetyltransferase inhibition, oncogene-induced senescence induction, and cancer biology research.

• AM251 Workflows for CB1 Receptor Research

  2026-08-17

  AM251 is a practical pharmacological switch for separating CB1-dependent signaling from broader endocannabinoid effects in neural, metabolic, and cell-based models. This workflow-focused guide connects receptor blockade with pain, appetite, cAMP, apoptosis, and behavioral readouts while emphasizing solvent control and interpretation limits.

• Phenytoin for Myelin and Sodium Channel Assays

  2026-08-17

  Phenytoin provides a practical chemical perturbation for linking voltage-gated sodium channel activity with dynamic myelin damage. This guide translates recent live-imaging findings into reproducible electrophysiology, organotypic-slice, and neurological disease model workflows, with formulation and troubleshooting advice.

• Rapamycin (Sirolimus): mTOR Research Guide

  2026-08-16

  Rapamycin, also called Sirolimus, is an FKBP12-dependent mTOR inhibitor used to study cell growth, immune activation, cancer metabolism, and mitochondrial disease. Its reported mTOR IC50 is approximately 0.1 nM, but assay conditions, exposure duration, and cell context determine experimental response.

• M1R/B6R Bispecific Antibodies for Orthopoxvirus Protection

  2026-08-15

  This study maps the binding and antiviral properties of monoclonal antibodies against the MPXV immunogens M1R and B6R, then applies those findings to antibody-cocktail and bispecific designs. Its most important translational result is the robust protection produced by a VH-CH1 switch region-inserting bispecific format in a VACV mouse model, while also highlighting the limits of extrapolating preclinical antibody data to human mpox therapy.

• SVA 3A/2B–DDX23 Antiviral Defense

  2026-08-14

  Li and colleagues identify a dual interaction in which host RNA helicase DDX23 restricts Senecavirus A (SVA), while viral 3A and 2B proteins use distinct caspase-linked mechanisms to reduce DDX23 protein abundance. The study combines expression genetics, pathway-inhibitor experiments, and reverse-genetics viruses to connect specific viral residues with replication, providing a framework for analyzing apoptosis-related antiviral restriction without equating pharmacological caspase inhibition with direct substrate cleavage.

• Dinaciclib (SCH727965): Assay Workflow Guide

  2026-08-14

  Use Dinaciclib as a multi-CDK perturbation tool to connect cell-cycle suppression with Rb dephosphorylation, apoptosis, and quantitative phenotype changes. This workflow emphasizes dose design, orthogonal validation, and careful interpretation when translating tissue-boundary mechanics into cancer research.

• L-Phenylephrine in Reliable Cell Assays

  2026-08-13

  Learn how L-Phenylephrine (SKU C3021) can support interpretable adrenergic α1A studies across viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects receptor pharmacology, sex-aware experimental design, solution handling, orthogonal readouts, and practical product selection.

• HOBt in Amide Bond Formation: Practical Workflows

  2026-08-13

  HOBt supports high-fidelity amide bond formation when stereochemical integrity and mild reaction conditions matter. This guide translates its use in peptide synthesis and medicinal chemistry into executable coupling workflows, optimization checkpoints, and troubleshooting strategies informed by a glucagon receptor antagonist study.

• Live-Dead Bacterial Staining Kit for Nanomaterials

  2026-08-12

  Use dual fluorescence to separate membrane-intact bacteria from membrane-compromised cells during antimicrobial nanomaterial studies. This workflow connects NucGreen dye and EthD-III staining with pH, magnetic-field, and time-course controls for more interpretable bacterial viability data.

• Amine Chemistry Governs Lung-Selective mRNA Delivery

  2026-08-12

  This JACS Au study combines a systematic library of cationic polymer micelles with SHAP and multitask Gaussian Process modeling to identify how amine chemistry controls mRNA binding, cellular delivery, viability, translation, and lung distribution. Its central practical implication is that optimal delivery requires a balanced interaction with mRNA rather than simply maximizing electrostatic binding.

• Resiquimod (R-848) Workflow for Immune Studies

  2026-08-11

  Resiquimod (R-848) gives researchers a practical way to activate TLR7/8 while tracking cytokine output, dendritic-cell maturation, and macrophage polarization. This guide translates the MR@CaP@HA tumor-ablation study into bench workflows for formulation screening, cancer immunotherapy research, and carefully bounded vaccine adjuvant development.

• Polymer-Pen 3D Gold Arrays for Reproducible SERS

  2026-08-11

  The reference study introduces a polymer pen lithography strategy for building ordered three-dimensional gold nanoparticle cluster arrays with tunable architecture. By combining patterned polyethylenimine scaffolds with electrostatic nanoparticle assembly, the authors achieved strong SERS enhancement and low substrate-to-substrate variation while retaining structural adjustability.

16758 records 1/1118 page Next 12345 下5页 Last page